Search results

Jump to navigation Jump to search

  • SPECT Biomarker Ctte
    :Co-chairs: Yuni Dewaraja, PhD; P. David Mozley, MD; John Seibyl, MD ...ile.v0.1_2016.04.15b.docx | QIBA DRAFT Profile with tracked changes - {Dr. Mozley}]] ''April 15, 2016''
    5 KB (673 words) - 18:46, 21 December 2023
  • Profile drafts
    ...docx | QIBA DRAFT Profile with tracked changes for recent additions - {Dr. Mozley}]] ''March 21, 2016'' ...docx | QIBA DRAFT Profile with tracked changes for recent additions - {Dr. Mozley}]] ''March 16, 2016''
    2 KB (221 words) - 20:27, 17 March 2017
  • Archive - Initial Target Selection and Roadmap
    ...Validation_Roadmap_VOL-CT_Image_Analysis.pdf|Validation Roadmap - P. David Mozley, MD]]
    606 bytes (81 words) - 14:35, 9 April 2015
  • Moc technical committee
    *Mozley PD (pharma industry co-chair) Merck & Co Inc/PhRMA
    36 KB (5,187 words) - 16:42, 23 July 2009
  • Resources
    ...Validation_Roadmap_VOL-CT_Image_Analysis.pdf|Validation Roadmap - P. David Mozley, MD]]
    235 bytes (28 words) - 18:45, 27 October 2008
  • QIBA vCT Profile v1.1 edit site
    • Mozley PD, (pharma industry co-chair) Merck & Co Inc/PhRMA
    40 KB (5,805 words) - 18:35, 4 September 2009
  • Profile: CT Lung Nodule Volume Measurement for Primary/Regional Nodes and Metastatic Sites
    *Mozley PD (pharma industry co-chair) Merck & Co Inc/PhRMA
    36 KB (5,191 words) - 14:47, 22 June 2009
  • Test joe protocols
    *Mozley PD (pharma industry co-chair) Merck & Co Inc/PhRMA
    31 KB (4,311 words) - 20:35, 29 May 2009
  • QIBA v-CT Chest
    *Mozley PD (pharma industry co-chair) Merck & Co Inc/PhRMA
    31 KB (4,311 words) - 20:44, 29 May 2009
  • Profile: CT Lung Nodule - Small Nodule in neoadjuvant Setting
    *Mozley PD (pharma industry co-chair) Merck & Co Inc/PhRMA
    35 KB (4,981 words) - 14:36, 8 June 2009
Retrieved from "https://qibawiki.rsna.org/index.php/Special:Search"